Category Archives: Obesity: Drugs

2nd patient dies in obesity drug trial

A second patient died in a late-stage trial of Zafgen Inc’s experimental obesity treatment, highlighting safety concerns associated with drugs that aim to treat a condition that affects one in three Americans. Shares of Zafgen tumbled more than 50 percent … Continue reading

Posted in Obesity: Drugs | Leave a comment

90 percent overlook key to weight loss

Orlando, Florida - Tens of millions of Americans vow each year to lose weight in the New Year, and while their intentions are good, most of the time their results are not. It’s estimated that only 8 percent of those … Continue reading

Posted in Diet Drugs, Human Behavior: Anger, Human Behavior: Anxiety, Human Behavior: Emotional Eating, Human Behavior: Fatigue, Human Behavior: Frustration, Human Behavior: Guilt, Human Behavior: Habits, Human Behavior: Impulse, Human Behavior: Sedentary, Human Behavior: Self Esteem, Human Behavior: Shame, Human Behavior: Stress, Nutrition, Nutrition: Appetite, Nutrition: Binge Eating, Nutrition: Comfort Food, Nutrition: Cookbooks, Nutrition: Dietitians, Nutrition: Diets, Nutrition: Fasting, Nutrition: Habits, Nutrition: Portion Sizes, Nutrition: Satiety, Nutrition: Yo-Yo Dieting, Obesity, Obesity: Drugs, Well Being | Leave a comment

Experts recommend weight loss drugs, surgery as supplement to lifestyle interventions

Washington, DC-The Endocrine Society today issued a Clinical Practice Guideline (CPG) on strategies for prescribing drugs to manage obesity and promote weight loss. The CPG, entitled “Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline,” was published online and … Continue reading

Posted in Commercial Fitness Industry, Obesity, Obesity: Bariatric Surgery, Obesity: Drugs | Comments Off on Experts recommend weight loss drugs, surgery as supplement to lifestyle interventions

The obesity drug that is failing patients due to lack of education about side-effects

A new study, published today in the Journal of Health Psychology, found that patients who gained weight 18 months after taking Orlistat attributed their weight-loss failure either to the side effects which have prevented them from sticking to the medication … Continue reading

Posted in Obesity: Drugs, Orlistat | Comments Off on The obesity drug that is failing patients due to lack of education about side-effects

Can messing with the myostatin protein trigger the body to go into fat-burning mode? A serious journal has the research.

NTU study finds ways to prevent muscle loss, obesity and diabetes A research study from Nanyang Technological University (NTU) has yielded important breakthroughs on how the body loses muscle, paving the way for new treatments for aging, obesity and diabetes. … Continue reading

Posted in Obesity: Drugs | Tagged | Comments Off on Can messing with the myostatin protein trigger the body to go into fat-burning mode? A serious journal has the research.

Obesity drug Qsymia gets FDA approval

The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. The drug is approved for use in adults with a body mass index (BMI) … Continue reading

Posted in Obesity: Drugs | 1 Comment

Homeopathic HCG diet products are illegal: FDA

HCG Makes Big Claims A Potentially Dangerous Diet Story Started Decades Ago Anyone who has ever been on a diet—and there are many of us—knows that there are sensible ways to lose weight. These include balanced diets, exercising and realistic … Continue reading

Posted in Alternative Medicine, Nutrition, Obesity, Obesity: Drugs | Comments Off on Homeopathic HCG diet products are illegal: FDA

Anti-obesity medications containing orlistat, including Alii and Xenical, under review in EU

The European Medicines Agency has started a review of orlistat-containing anti-obesity medicines, to determine whether the very rare cases of hepatic injury have an impact on their benefit-risk profile and conditions of use. The review includes the centrally authorised prescription-only … Continue reading

Posted in Health Care: Medical Errors, Obesity, Obesity: Drugs, Orlistat, Pharmaceuticals | Comments Off on Anti-obesity medications containing orlistat, including Alii and Xenical, under review in EU

Why some of us will be fat forever

The Cheesecake Factory Celebrates National Cheesecake History Month and National Cheesecake Day Offering Any Slice at Half Price on July 30 Hershey’s Chocolate Bar Cheesecake Introduced to Culminate National Cheesecake Month CALABASAS HILLS, Calif.-(BUSINESS WIRE)-As National Cheesecake History Month concludes, … Continue reading

Posted in Cancer, Cholesterol, Cognitive Impairment, Commercial Fitness Industry, Corporate Wellness, Dementia, Diabetes, Exercise, Fitness, Fracture Risks, Gastroenterology, Health Care: Costs, Heart Disease, Human Behavior, Human Behavior: Addictive, Human Behavior: Conformity, Human Behavior: Happiness, Human Behavior: Impulse, Human Behavior: Loneliness, Human Behavior: Stress, Hypertension, Insulin Resistance, Mental Health, Nutrition, Nutrition: Calorie Restriction, Nutrition: Dietitians, Nutrition: Diets, Nutrition: Eating Disorders, Nutrition: Fat, Nutrition: Food: Chocolate, Nutrition: Food: Dairy Products, Nutrition: Food: Sugar, Nutrition: Fructose, Nutrition: Information: Confusion, Nutrition: Junk Food, Obesity, Obesity: Bariatric Surgery, Obesity: Drugs, Pediatric Health, Proactive Prevention, Public Health, Science Updates, Wellness, Women's Health | Comments Off on Why some of us will be fat forever

Supplement takers may think they’re invulnerable to health problems, make poor decisions: Psychological Science journal

Do you belong to the one-half of the population that frequently uses dietary supplements with the hope that it might be good for you? Well, according to a study published in an upcoming issue of Psychological Science, a journal of … Continue reading

Posted in Nutrition, Nutrition: Information: Confusion, Obesity: Drugs | Comments Off on Supplement takers may think they’re invulnerable to health problems, make poor decisions: Psychological Science journal

Diet drug Xenical tied to acute kidney injury in new study

Obesity is a significant health problem that is growing in prevalence. Orlistat (Xenical; Roche, Basel, Switzerland), an inhibitor of pancreatic lipases that limits the intestinal absorption of dietary fat, has proven effective in augmenting weight loss. In the United States, … Continue reading

Posted in Health Care: Medical Errors, Nephrology: Acute Kidney Injury, Nutrition, Obesity: Drugs | Comments Off on Diet drug Xenical tied to acute kidney injury in new study

FDA: Beware of fraudulent weight-loss dietary supplements

Source: FDA Magic diet pill! Melt your fat away! Diet and exercise not required! Messages like these on weight-loss products taunt consumers looking for a quick and easy way to shed pounds. But these products don’t live up to their … Continue reading

Posted in Nutrition, Nutrition: Dietitians, Nutrition: Diets, Nutrition: Information, Nutrition: Information: Confusion, Nutrition: Packaging, Obesity, Obesity: Drugs | Comments Off on FDA: Beware of fraudulent weight-loss dietary supplements

Why mouth can’t hear brain telling it to STOP EATING

Researchers at UT Southwestern Medical Center have identified a signaling pathway in the brain that’s sufficient to induce cellular leptin resistance, a problem that decreases the body’s ability to “hear” that it is full and should stop eating. “Leptin resistance … Continue reading

Posted in Brain, Obesity, Obesity: Drugs | Comments Off on Why mouth can’t hear brain telling it to STOP EATING

New book, Why We Get Fat, is #1 in nutrition and nursing categories

The nutrient composition of the diet is less important than whether or not the subject can live with the diet and is willing to do so for as long as it takes — ideally, a life time, says the author. … Continue reading

Posted in Alternative Medicine, Arthritis, Atherosclerosis, Back Pain, Brain, Business, Cancer, Cholesterol, Chronic Fatigue Syndrome, Commercial Fitness Industry, Corporate Wellness, Diabetes, Exercise, Exercise: Benefits, Exercise: Incentives, Exercise: Walking, Fitness, Fitness: Strength Training, Fitness: Yoga, Gout, Health Care, Health Care: Costs, Health Care: Disparities, Health Care: Health Insurance, Health Care: Reform, Health Coaching, Heart Disease, Heart Health, Human Behavior, Hypertension, Men's Health, Mental Health, Nutrition, Nutrition: Cookbooks, Nutrition: Dietitians, Nutrition: Diets, Nutrition: Fat, Nutrition: Fructose, Nutrition: Information, Nutrition: Information: Confusion, Nutrition: Junk Food, Obesity, Obesity: Bariatric Surgery, Obesity: Drugs, Parenting, Pediatric Health, Pediatric Health: TV Watching, Proactive Prevention, Public Health, Sports Medicine, Wellness, Women's Health | Comments Off on New book, Why We Get Fat, is #1 in nutrition and nursing categories

Fruta Planta “natural” supplement recall

Godi International, Corp., located in South Florida is announcing a recall of Fruta Planta weight loss dietary supplements because the products contain Sibutramine an undeclared drug ingredient. The FDA lab analysis of the dietary supplements found the Authentic Formula Fruta … Continue reading

Posted in Men's Health, Obesity: Drugs, Pharmaceuticals, Proactive Prevention, Women's Health | Tagged dietary supplement recall, Fruta Planta recall, Godi recall, sibutramine | Comments Off on Fruta Planta “natural” supplement recall

FDA warns consumers not to use Fruta Planta weight loss products

FDA warns consumers not to use Fruta Planta weight loss products Fast Facts * PRock Marketing LLC, of Kissimmee, Fla., is recalling all lots of Fruta Planta and Reduce Weight Fruta Planta. This is a single product marketed under two … Continue reading

Posted in Men's Health, Nutrition, Obesity: Drugs, Proactive Prevention, Recalls, Women's Health | Tagged Fruta Planta recall, PRock recall, sibutramine | Comments Off on FDA warns consumers not to use Fruta Planta weight loss products

Anti-obesity drug post mortem

As part of the Year in Review series, MedPage Today reporters are revisiting major news stories and following up with an analysis of the impact of the original report, as well as subsequent news generated by the initial publication. Here’s … Continue reading

Posted in Cholesterol, Nutrition, Obesity, Obesity: Drugs, Pharmaceuticals, Proactive Prevention, Women's Health | Tagged CRESCENDO, rimonabant | Comments Off on Anti-obesity drug post mortem

Dietary supplement manufacturers get FDA letter

In a letter sent today to dietary supplement manufacturers, the U.S. Food and Drug Administration expressed concern about undeclared or deceptively labeled ingredients in products marketed as dietary supplements. These substances include the active ingredients in FDA-approved drugs or their … Continue reading

Posted in Estrogen, Men's Health, Obesity, Obesity: Drugs, Proactive Prevention, Women's Health | Tagged ArimaDex, aromatase inhibitors, Clomed, Daniel H. Solomon, deceptively labeled supplements, Merida, novel synthetic steroids, sibutramine, Slim-30, Slimming Beauty, Tren Xtreme | Comments Off on Dietary supplement manufacturers get FDA letter

Common links between obesity and drug abuse found

New animal research helps explain why some eat without hunger or to excess. The studies explore the biological effects of poor eating habits, showing that high-fat diets cause lasting brain changes that may impair healthy eating. Additional studies show that … Continue reading

Posted in Exercise, Nutrition, Obesity, Obesity: Drugs, Pharmaceuticals, Proactive Prevention, Women's Health | Comments Off on Common links between obesity and drug abuse found